Eli Lilly 13 may 2026 Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss - BioPharma Dive
Eli Lilly 13 may 2026 Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies - Fierce Pharma
Charles River 13 may 2026 Charles River Laboratories stock (US1591881009): Shareholders approve 2026 incentive plan - AD HOC NEWS
FierceBiotech 13 may 2026 Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
FierceBiotech 13 may 2026 With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
Merck & Co. 13 may 2026 Cortisone Shots Market 2026 | Merck & Co, Pfizer, Bristol-Myers Squibb, Novartis, Pharmascience etc. - openPR.com
Siemens Healthineers 13 may 2026 Siemens Healthineers Atellica Testosterone Assay Receives CDC Certification - Clinical Lab Products